Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by debilitating heterotopic ossification (HO). The retinoic acid receptor gamma agonist, palovarotene, and antibody-mediated activin A blockade have entered human clinical trials, but how these therapeutic modalitie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lees-Shepard, John B, Nicholas, Sarah-Anne E, Stoessel, Sean J, Devarakonda, Parvathi M, Schneider, Michael J, Yamamoto, Masakazu, Goldhamer, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2018
Materias:
Human Biology and Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143342/
https://www.ncbi.nlm.nih.gov/pubmed/30226468
http://dx.doi.org/10.7554/eLife.40814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143342/
https://www.ncbi.nlm.nih.gov/pubmed/30226468
http://dx.doi.org/10.7554/eLife.40814

Ejemplares similares